Abstract
The aim of the present work was to prepare, characterize and evaluate the solubility and dissolution behavior of ketoprofen co-crystals. Fusion method was employed for the preparation of ketoprofen co-crystals. The co-formers selected were cinnamic acid, glutaric acid, maleic acid, malonic acid, nicotinamide, oxalic acid, p-amino-benzoic acid, pamino salicylic acid, saccharin and urea. The prepared ketoprofen co-crystals were characterized by FT-IR, DSC and XRD. Ketoprofen co-crystals were evaluated for solubility and dissolution. Micromeritic properties were evaluated for cocrystal exhibiting higher solubility. A Shift in the IR peaks was observed for all the prepared co-crystals with no presence of additional peaks. DSC studies showed decrease in the heat of fusion from 257.74 to 50.39 J/g and melting point of drug from 95.80 to 73.57°C in the co-crystals. XRD peaks exhibited different peak patterns than peaks shown by the pure ketoprofen. All the preparations exhibited enhanced aqueous solubility as well as dissolution when compared with pure ketoprofen. Amongst the co-crystals prepared, Ketoprofen-p-Amino-salicylic acid co-crystals, exhibited 14 fold increases in aqueous solubility and in vitro release was found to be 93.41% in 60 mins. This work demonstrates the potential of cocrystallization by fusion as screening method for particle engineering. The results demonstrate the feasibility of pharmaceutical co-crystal design for ketoprofen.
Keywords: Co-crystals, Co-formers, Fusion technique, Ketoprofen, Solubility.
Current Drug Therapy
Title:Enhancing Aqueous Solubility of Ketoprofen by Fusion Technique Using Suitable Co-formers
Volume: 9 Issue: 3
Author(s): Rudra Vaghela, Parthasarathi. K. Kulkarni, Umme Hani, Vegasna Naga Sravan Kumar Varma and Raizaday Abhay
Affiliation:
Keywords: Co-crystals, Co-formers, Fusion technique, Ketoprofen, Solubility.
Abstract: The aim of the present work was to prepare, characterize and evaluate the solubility and dissolution behavior of ketoprofen co-crystals. Fusion method was employed for the preparation of ketoprofen co-crystals. The co-formers selected were cinnamic acid, glutaric acid, maleic acid, malonic acid, nicotinamide, oxalic acid, p-amino-benzoic acid, pamino salicylic acid, saccharin and urea. The prepared ketoprofen co-crystals were characterized by FT-IR, DSC and XRD. Ketoprofen co-crystals were evaluated for solubility and dissolution. Micromeritic properties were evaluated for cocrystal exhibiting higher solubility. A Shift in the IR peaks was observed for all the prepared co-crystals with no presence of additional peaks. DSC studies showed decrease in the heat of fusion from 257.74 to 50.39 J/g and melting point of drug from 95.80 to 73.57°C in the co-crystals. XRD peaks exhibited different peak patterns than peaks shown by the pure ketoprofen. All the preparations exhibited enhanced aqueous solubility as well as dissolution when compared with pure ketoprofen. Amongst the co-crystals prepared, Ketoprofen-p-Amino-salicylic acid co-crystals, exhibited 14 fold increases in aqueous solubility and in vitro release was found to be 93.41% in 60 mins. This work demonstrates the potential of cocrystallization by fusion as screening method for particle engineering. The results demonstrate the feasibility of pharmaceutical co-crystal design for ketoprofen.
Export Options
About this article
Cite this article as:
Vaghela Rudra, Kulkarni K. Parthasarathi., Hani Umme, Varma Naga Sravan Kumar Vegasna and Abhay Raizaday, Enhancing Aqueous Solubility of Ketoprofen by Fusion Technique Using Suitable Co-formers, Current Drug Therapy 2014; 9 (3) . https://dx.doi.org/10.2174/1574885510666141209233056
DOI https://dx.doi.org/10.2174/1574885510666141209233056 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Obesity and Inflammation – Targets for OA Therapy
Current Drug Targets Melatonin Alleviates Pyroptosis of Retinal Neurons Following Acute Intraocular Hypertension
CNS & Neurological Disorders - Drug Targets An Update on Potential Molecular Mechanisms Underlying the Actions of Snake Venom L-amino Acid Oxidases (LAAOs)
Current Medicinal Chemistry Vitiligo and Allergic Complications from Orthopaedic Joint Implants: The Role of Benzoyl Peroxide
Recent Patents on Inflammation & Allergy Drug Discovery The Cyclin-Dependent Kinase Inhibitor p21CDKN1A as a Target of Anti-Cancer Drugs
Current Cancer Drug Targets Negative Glucocorticoid Receptor Response Elements and their Role in Glucocorticoid Action
Current Pharmaceutical Design Dynamics of Toll-like Receptors Signaling in Skeletal Muscle Atrophy
Current Medicinal Chemistry Aminobisphosphonates as New Weapons for γ δ T Cell-Based Immunotherapy of Cancer
Current Medicinal Chemistry Pharmacological Modulation of p53 Function in Cancer Therapy
Current Signal Transduction Therapy Synthesis of (±) Travoprost and its Analogs
Letters in Organic Chemistry Deciphering Supportive Treatment Strategies for Toxic Epidermal Necrolysis
Current Drug Safety Orekhov`s Method: Reassessment of In vitro Lipid Uptake Assays
Recent Advances in Cardiovascular Drug Discovery (Discontinued) Cutaneous Larva Migrans
Recent Patents on Inflammation & Allergy Drug Discovery Development of a STAT5 Phosphorylation Assay as a Rapid Bioassay to Assess Interleukin-7 Potency
Current Pharmaceutical Biotechnology Soy Isoflavone Alleviates Aβ1-42-Induced Impairment of Learning and Memory Ability Through the Regulation of RAGE/LRP-1 in Neuronal and Vascular Tissue
Current Neurovascular Research Hepatotoxic Effect of <i>Lafoensia pacari</i> A. St. Hil. (Lythraceae) on a Diet-Induced Obese Mice Model
Protein & Peptide Letters An Insight into the Current Perspective and Potential Drug Targets for Visceral Leishmaniasis (VL)
Current Drug Targets Evaluation of Toll-like Receptor 2 Gene Expression in Rheumatoid Arthritis and Correlation with the Disease Activity
Current Chemical Biology Metabolomic Approach in Probing Drug Candidates
Current Topics in Medicinal Chemistry “Something is Wrong in the Ras Kingdom” - Evidence for the Involvement of p21Ras/MAP Kinase in Autoimmune Diseases
Current Rheumatology Reviews